Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri Sabnis

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Research|February 5, 2009
Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogenGauri Sabnis, Adam Schayowitz, Olga Goloubeva, et al.
Expert Review of Anticancer Therapy|February 25, 2014
Advances in mechanisms of resistance to aromatase inhibitorsSaranya Chumsri, Amanda Schech, Chakkapong Chakkabat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Therapeutic observations in MCF-7 aromatase xenograftsAngela Brodie, Danijela Jelovac, Luciana Macedo, et al.
Molecular Cancer Therapeutics|January 19, 2008
Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitroAdam Schayowitz, Gauri Sabnis, Vincent C O Njar, et al.
Urologic Oncology|December 30, 2008
The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancerAngela Brodie, Vincent Njar, Luciana Furtado Macedo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 22, 2005
Model systems: mechanisms involved in the loss of sensitivity to letrozoleAngela Brodie, Danijela Jelovac, Gauri Sabnis, et al.
BMC Cancer|June 11, 2011
GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cellsTesfom Abrhale, Angela Brodie, Gauri Sabnis, et al.
Scientific Reports|August 2, 2016
Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the peripheryIstvan Merchenthaler, Malcolm Lane, Gauri Sabnis, et al.
Cancer Research|June 17, 2005
Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozoleDanijela Jelovac, Gauri Sabnis, Brian J Long, et al.
Journal of Medicinal Chemistry|June 12, 2008
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitroLalji K Gediya, Aakanksha Khandelwal, Jyoti Patel, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|February 5, 2009
Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogenGauri Sabnis, Adam Schayowitz, Olga Goloubeva, et al.
Expert Review of Anticancer Therapy|February 25, 2014
Advances in mechanisms of resistance to aromatase inhibitorsSaranya Chumsri, Amanda Schech, Chakkapong Chakkabat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Therapeutic observations in MCF-7 aromatase xenograftsAngela Brodie, Danijela Jelovac, Luciana Macedo, et al.
Molecular Cancer Therapeutics|January 19, 2008
Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitroAdam Schayowitz, Gauri Sabnis, Vincent C O Njar, et al.
Urologic Oncology|December 30, 2008
The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancerAngela Brodie, Vincent Njar, Luciana Furtado Macedo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 22, 2005
Model systems: mechanisms involved in the loss of sensitivity to letrozoleAngela Brodie, Danijela Jelovac, Gauri Sabnis, et al.
BMC Cancer|June 11, 2011
GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cellsTesfom Abrhale, Angela Brodie, Gauri Sabnis, et al.
Scientific Reports|August 2, 2016
Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the peripheryIstvan Merchenthaler, Malcolm Lane, Gauri Sabnis, et al.
Cancer Research|June 17, 2005
Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozoleDanijela Jelovac, Gauri Sabnis, Brian J Long, et al.
Journal of Medicinal Chemistry|June 12, 2008
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitroLalji K Gediya, Aakanksha Khandelwal, Jyoti Patel, et al.
Pageof 4